Pharma Deal Dynamics
Martin shares his experience of navigating the differences between East Coast and West Coast investment styles while attempting to secure a pharma deal with Peter. He highlights the unique valuation of biopharma assets, emphasizing that their worth can be significant whether they are in development or not. The discussion reveals how the potential of a drug can lead to substantial financial opportunities, even before it reaches the market.In this clip
From this podcast
My First Million
Martin Shkreli Reveals How He Made His First $100 Million (#445)
Related Questions